INTRODUCTION
============

Transient receptor potential (TRP) channels have emerged as cellular sensors for a variety of environmental and endogenous stimuli ([@bib16]). Synthetic and naturally occurring organic compounds (capsaicin, menthol, and 2-aminoethyoxy diphenylborinate \[2-APB\]), membrane lipids such as phosphatidylinositol phosphates (PIPs) and products of lipid metabolism (diacylglycerol \[DAG\], eicosanoids, and arachidonate), inorganic ions (Ca^2+^, Mg^2+^, and H^+^), and transmembrane voltage and temperature changes modulate or directly activate a variety of TRP channels ([@bib65]). A subset of "polymodal" TRP channels including TRPV1, TRPV3, TRPA1, TRPM4, and TRPM8 respond to multiple distinct activators, suggesting that they are likely to function as important integrators of convergent cellular stimuli. Depending on the cell- and tissue-specific contexts of their expression, polymodal TRP channels are poised to perform a variety of physiological functions in health and disease ([@bib56]).

TRPV3 (human TRP channel, vanilloid family, subtype 3; NCBI Protein database accession no. [AF514998](AF514998)) is a Ca^2+^-permeable cation channel that is activated by moderate thermal heating (≥32°C) in the range where warmth is sensed ([@bib61]; [@bib70]; [@bib84]). Organic chemicals such as 2-APB and structurally related compounds, plant-derived compounds (camphor, carvacrol, and thymol), and unsaturated fatty acids also activate or potentiate TRPV3 activation ([@bib61]; [@bib70]; [@bib84], [@bib85], [@bib86]; [@bib12]; [@bib30]; [@bib63]). TRPV3 also displays an unusual sensitization to repeated activation that was attributed to modulation of channel activity by Ca^2+^ and calmodulin ([@bib82]; [@bib63]). TRPV3 protein and mRNA are highly expressed in epidermal keratinocytes, and TRPV3 currents were reported in primary rodent keratinocytes and immortalized 308 cells ([@bib61]; [@bib70]; [@bib84], [@bib86]; [@bib11], [@bib13]; [@bib30]; [@bib9]). Targeted deletion of TRPV3 in mice abolishes TRPV3 currents in keratinocytes, causes a wavy hair/curly whisker phenotype and erythroderma, and alters thermal selection, indicating that the channel is necessary for normal hair development, epidermal barrier formation, and thermosensation ([@bib53]; [@bib9]). In addition, the release of ATP and transforming growth factor α (TGF-α) elicited by TRPV3 agonists and thermal warming of primary keratinocytes is attenuated in TRPV3-null mice ([@bib48]; [@bib9]). Keratinocyte secretion of chemical messengers and growth factors thus transmits important information to proliferating and differentiating keratinocyte as well as sensory neurons ([@bib40]; [@bib46]; [@bib48]; [@bib9]). Interestingly, spontaneous autosomal dominant mutations in TRPV3 that result in constitutive channel activity cause hairlessness and increase susceptibility to dermatitis and inflammatory skin lesions in rodents ([@bib3]; [@bib83]; [@bib33]; [@bib87]). TRPV3-mediated Ca^2+^ influx and depolarization may therefore represent an important link in signaling cascades that control cellular activation, the release of autocrine and paracrine factors, hair morphogenesis, and cell proliferation in keratinocytes.

Studies performed using heterologous expression systems showed that TRPV3 currents are also strongly potentiated by stimulation of G~q/11~-coupled receptors in a PLCβ-dependent fashion ([@bib86]). Activation of PLC-coupled growth factor receptors also enhances TRPV3-dependent Ca^2+^ influx ([@bib9]). The precise mechanism of TRPV3 potentiation by PLC-coupled receptors is unknown, but the response is inhibited by U73122, suggesting that stimulation of PLC activity may relieve a tonic inhibitory influence on channel opening that limits the amount of TRPV3 current under resting conditions ([@bib86]; [@bib9]). PLCβ mediates hydrolysis of plasma membrane phosphatidylinositol (4,5) bisphosphate (PI(4,5)P~2~), which is known to modulate the activity of a plethora of ion channels and transporters in the plasma membrane, including several members of the TRP channel family ([@bib20]; [@bib68]; [@bib59]; [@bib75]; [@bib66]). We therefore hypothesized that TRPV3 channel activity might be negatively regulated by resting levels of PI(4,5)P~2~, such that G~q/11~-coupled receptor activation would result in an increase in TRPV3 conductance.

Elucidating the mechanisms by which PIPs regulate the function of ion channels and transporters is an area of active investigation, but the details of protein--PIP interactions are not well understood. Putative PI(4,5)P~2~-binding motifs identified in various integral membrane proteins commonly contain several basic amino acid residues that are predicted to form electrostatic interactions with negatively charged phosphates on the inositol ring, but lipid contacts with noncharged residues are likely to contribute to PIP specificity; to date, no consensus PI(4,5)P~2~-binding sequence has emerged ([@bib68]; [@bib75]). In TRPV1, TRPV5, TRPM5, and TRPM8, modulation of channel activity by PI(4,5)P~2~ is sensitive to mutations of residues located in the TRP domain, an ∼25-residue motif that is conserved in most TRP channel subfamilies ([@bib59]; [@bib66]). Within the TRP domain is a six--amino acid TRP box motif that typically contains at least two basic residues interspersed with hydrophobic amino acids and is predicted to form an amphipathic helix ([@bib52]; [@bib65]; [@bib6]). A nearby poly basic motif, which is found C-terminal to the TRP domain, has also been implicated in PI(4,5)P~2~ binding to TRPV1 ([@bib77]). The functional consequences of PI(4,5)P~2~ binding range from inhibition ([@bib18]; [@bib60]) to bidirectional modulation ([@bib10]; [@bib72]; [@bib45]) to activation ([@bib69]; [@bib42]; [@bib43]; [@bib67]; [@bib57]; [@bib37]; [@bib51]; [@bib77]).

We show here that the activation of G~q/11~-coupled receptors alters the voltage dependence of activation and potentiates the amplitude of current carried by endogenous TRPV3 channels in primary human keratinocytes. The activation of M~1~ receptors in HM1 cells (HM1 is a HEK-293 cell clone that stably expresses the G~q/11~-coupled human muscarinic acetylcholine receptor type 1 \[M~1~\]) ([@bib62]) additionally sensitizes recombinant TRPV3 channels to activation by thermal heating and increases the potency of the channel agonist 2-APB. Pharmacological depletion of membrane PI(4,5)P~2~ mimics the effect of G~q/11~-coupled receptor stimulation. In excised patches, the open probability of TRPV3 single-channel currents is reduced by a water-soluble PI(4,5)P~2~ analogue. Finally, we identify two basic residues in the TRP domain that are required for PI(4,5)P~2~-dependent modulation of TRPV3. The majority of our data are well explained by a mechanism that involves tonic suppression of TRPV3 channel activity by PI(4,5)P~2~ and rapid relief by receptor-mediated activation of PLCβ.

MATERIALS AND METHODS
=====================

DNA constructs, cells, and transfection
---------------------------------------

cDNA encoding human TRPV3 ([@bib84]) was subcloned into pIRES-EGFP (Invitrogen) as an EcoRV/NotI fragment for expression in mammalian cells. TRPV3 R696A and K705A mutagenesis was performed using overlap extension PCR with synthetic complementary oligonucleotides ([@bib25]). All cDNA mutations were verified by DNA sequencing. HM1 cells ([@bib62]) were maintained in DMEM supplemented with 10% fetal bovine serum, 100 µg/ml penicillin/streptomycin (Invitrogen), and 0.5 mg/ml G-418 (A.G. Scientific, Inc.) at 37°C, 5% CO~2~. Cells were transfected using the calcium phosphate precipitation method ([@bib91]). Transfected cells were trypsinized and plated onto glass coverslips and used for electrophysiological recordings 24--48 h after transfection. Transfected cells were identified by GFP fluorescence before electrophysiological recording.

Freshly collected human skin was processed as described by [@bib35]. Human keratinocytes were provided by the BG University Hospital Bergmannsheil (Ruhr University, Bochum, Germany) and maintained in complete keratinocyte medium (DMEM/Ham's F12 \[3:1; Invitrogen\], 10% FBS, 1% penicillin/streptomycin \[Invitrogen\], 5 µg/ml human insulin \[Sigma-Aldrich\], 24.3 µg/ml adenine \[Sigma-Aldrich\], 1 µM isoproterenol \[Sigma-Aldrich\], 0.8 µg/ml hydrocortisone \[Sigma-Aldrich\], 1.36 ng/ml triiodothyronine \[Sigma-Aldrich\], and 20 ng/ml human EGF \[Sigma-Aldrich\]) at 37°C, 5% CO~2~, for four passages. Keratinocytes were trypsinized and plated onto glass coverslips for electrophysiological recordings 24--48 h later.

Electrophysiology
-----------------

The standard bath solution used for whole cell recordings contained (in mM): 139 NaCl, 5 KCl, 10 HEPES, 10 glucose, 2 MgCl~2~, and 1.8 BaCl~2~, pH 7.4 with NaOH. The pipette solution used to acquire 2-APB concentration--response curves and heat-evoked currents contained (in mM): 120 cesium methanesulfonate (CsMeSO~3~), 10 EGTA, 10 HEPES, 2 MgCl~2~, and 3.15 CaCl~2~ (free \[Ca^2+^\] ≈ 50 nM), pH 7.3 with CsOH. For experiments involving muscarinic and purinergic receptor activation, the pipette solution contained (in mM): 120 CsMeSO~3~, 10 1,2-Bis(2-aminophenoxy)ethane-*N,N,N′,N′*-tetraacetic acid (BAPTA), 10 HEPES, 2 CaCl~2~ (free \[Ca^2+^\] ≈ 50 nM), 0.3 Na-GTP, 2 Mg-ATP, and 8 NaCl, pH 7.3 with CsOH. Ca^2+^-free pipette solution contained (in mM): 120 CsMeSO~3~, 10 BAPTA, 10 HEPES, 0.3 Na-GTP, 2 Mg-ATP, and 12 NaCl (free \[Ca^2+^\] \< 10 nM), pH 7.3 with CsOH. The development of nonspecific leak currents during thermal heating was assessed by superfusing an Na^+^-free bath solution (in mM: 150 NMDG, 10 HEPES, and 10 glucose, pH 7.4 with HCl) at the peak of the temperature ramp. Cells displaying measurable inward currents in the presence of NMDGCl were omitted from analysis. The pipette and bath solution used for excised inside-out patch recordings was symmetrical (in mM): 145 NaCl, 5 CsCl~2~, 20 HEPES, and 1 EGTA, pH 7.4 with NaOH. Inside-out patches were washed by bath superfusion after excision and reagents were added by perfusion (∼1 min), followed by incubation in a still bath chamber (total time of exposure to the indicated reagents is indicated by horizontal bars in the figures); subsequent washout was accomplished by restarting the superfusion. For cell-attached recordings, NaCl in the bath solution was replaced by KCl. Free calcium concentrations were calculated using MaxChelator.

Unless otherwise indicated, recordings were performed at room temperature (21--24°C). In some experiments, bath solution was regulated using a bipolar temperature controller and an in-line heater/cooler with continuous superfusion (Warner Instruments). The temperature of the superfusate was recorded using a thermistor placed in close proximity to the cell.

Membrane voltage was controlled and currents were recorded using an amplifier (EPC7 Plus; HEKA) interfaced with a PC computer running Pulse and PulseFit software (HEKA). Whole cell current recordings were acquired at 5--10 kHz and low-pass filtered at 2 kHz. Capacitance correction and series resistance compensation (30--50%) were routinely used. Excised patch recordings were acquired at 10 kHz and low-pass filtered at 5 kHz. Currents were further digitally filtered offline for display purposes. For both wild-type (WT) TRPV3 and TRP domain mutants, currents were activated by 2-APB at 0.3 times its respective \[EC~50~\] to minimize irreversible entry of channels into the I2 conducting state and to control for changes in 2-APB potency observed in TRPV3 mutants.

Data analysis
-------------

Data were analyzed using Pulse and PulseFit (HEKA), OriginPro (OriginLab), IgorPro (WaveMetrics), Clampfit 9 (Axon Instruments), and Excel (Microsoft). Data are expressed as mean ± SEM unless otherwise noted. Statistical comparisons were made using Student's unpaired *t* test. Concentration--response relations were fitted with a Hill equation of the form I = I~max~ (\[X\]^n^/EC~50~^n^ + \[X\]^n^), where I is current, \[X\] is ligand concentration, EC~50~ is half-maximal current, and n is the Hill coefficient. In some cases, n was constrained during the curve fitting. The thermal coefficient (Q~10~) for temperature-dependent activation of TRPV3 currents was calculated from the slope of the steep phase of log(*I*) versus 1,000/T (1/°K) plots, determined by linear regression fits (y = A + B \* X, where B is the slope and A is the intercept). Peak tail current amplitude (I~TAIL~) was calculated by extrapolating the time-decaying current to the instant of membrane voltage change (t = 0) using mono-exponential fits. The I~TAIL~--V relation for each cell was fitted to a Boltzmann function (I = I2 + (I1--I2)/(1 + exp((V--V~0~)/dV)), where I is current, I1 is current minimum, I2 is current maximum, and V is membrane voltage). Where the data were not well fit to a complete Boltzmann function (i.e., in the absence of 2-APB), we empirically determined an apparent threshold for voltage-dependent activation (V~THR~) from the inspection of tail currents elicited by voltage steps in +20-mV increments, as described previously ([@bib54]). The most negative voltage that generated I~TAIL~, which was unambiguously larger than the background current, was designated as V~THR~. Single-channel amplitudes were estimated by Gaussian fits to all-points histograms and direct inspection of single-channel records. Open probability (NP~OPEN~) was computed by the equation NP~OPEN~ = T~OPEN~/T~OPEN~ + T~CLOSED~, where N is channel number, P~OPEN~ is open probability, T~CLOSED~ is total closed time, and T~OPEN~ is total open time, using Clampfit 9.2 (Axon Instruments). We selected patches with low basal channel activity for excised patch recordings.

Chemicals
---------

2-APB, camphor, carvacrol, probenecid, allyl isothiocyanate, menthol, carbamylcholine (CCh), wortmannin (WM), phenylarsine oxide (PAO), BAPTA, EGTA, NMDG, and capsaicin were from Sigma-Aldrich. Ruthenium red was purchased from EMD. ATP was from Roche, purified bacterial phosphatidylinositol-specific PLC (PI-PLC) was obtained from Invitrogen, and diC8-PIPs and anti-PI(4,5)P~2~ mouse monoclonal antiserum (mAb) were from Echelon Biosciences.

Online supplemental material
----------------------------

Fig. S1 shows current responses in primary human keratinocytes to various TRP channel agonists and compares the single-channel I-V relations of endogenous keratinocyte and expressed TRPV3 channels. Fig. S2 illustrates changes in the ligand, voltage, and temperature sensitivity that result from R696A and K705A mutations. Fig. S3 shows that R696A and K705A display reduced sensitivity to modulation of membrane PI(4,5)P~2~ levels in cell-free membrane patches. The online supplemental material is available at <http://www.jgp.org/cgi/content/full/jgp.200910388/DC1>.

RESULTS
=======

Endogenous TRPV3 currents in primary human keratinocytes are potentiated by G~q/11~-coupled purinergic receptor activation
--------------------------------------------------------------------------------------------------------------------------

We measured membrane currents elicited by voltage steps in primary cultures of human epidermal keratinocytes using the whole cell voltage clamp mode and a Cs^+^-based pipette solution that blocks most outward K^+^ channel current but permits measurement of outward conductances mediated by nonselective cation channels. Superfusion of the nonselective TRPV1-3 channel agonist 2-APB (30 µM) typically activated small voltage-dependent currents with steady-state outward rectification that reversed near 0 mV ([Fig. 1, A and B](#fig1){ref-type="fig"}). Carvacrol and camphor, but not capsaicin, probenecid, allyl isothiocyanate, or menthol, elicited currents with a similar steady-state I-V relation ([Fig. S1](http://www.jgp.org/cgi/content/full/jgp.200910388/DC1)), indicating that the observed currents were most likely a result of activation of TRPV3 and not TRPV1, TRPV2, TRPA1, or TRPM8 channels, respectively ([@bib29]; [@bib71]; [@bib4]; [@bib19]; [@bib2]). TRPV4 channels, which are also expressed in keratinocytes, are insensitive to 2-APB ([@bib12]). Ruthenium red, a voltage-dependent blocker of expressed TRPV3 and TRPV4 ([@bib61]; [@bib70]; [@bib79]; [@bib84]; [@bib12]), eliminated only the inward component of 2-APB--activated current, as expected (Fig. S1). The slope conductance of 2-APB--activated single-channel currents measured in inside-out membrane patches excised from primary keratinocytes (184.6 ± 2.1 pS) was close to that measured in patches from HM1 cells transfected with human TRPV3 cDNA (206.3 ± 1.6 pS; Fig. S1) under identical recording conditions. Collectively, these data indicate that the membrane currents measured under our experimental conditions in primary human keratinocytes are attributable to the expression of functional TRPV3 channels.

![Endogenous TRPV3 currents in primary human keratinocytes are potentiated by G~q/11~-coupled purinergic receptor activation. (A) Representative currents elicited by voltage steps to +80 mV (filled circles) or −80 mV (open circles) in the presence of 30 µM 2-APB (black bars) before and after exposure to 100 µM ATP (open bar). (B) Representative steady-state I-V relations taken at time points indicated in A: *a*, basal (circles); *b*, 30 µM 2-APB (squares); *c*, 30 µM 2-APB plus 100 µM ATP (triangles). (C) Representative currents (bottom) evoked by steps to the indicated voltage (top) at times *a*,*b*, and*c* indicated in A. Dashed line indicates the zero current level. (D) I~TAIL~-V relation for voltage-dependent currents elicited in the presence of 2-APB before (squares) and after (triangles) exposure to ATP. Data are from the experiment shown in A, and lines represent fits to a Boltzmann function. Note that the midpoint of the Boltzmann fit (V~0.5~) shifts negatively and I~TAIL~ at negative voltages (VIF) increases after ATP exposure. (E) Average change in step current at +80 mV (open bars) and −80 mV (shaded bars) after exposure to ATP (left) or vehicle control (right). (F) Average change in V~0.5~ before and after ATP (open bar) or vehicle control (hatched bar) exposure. (G) Average VIF determined from the saturation of Boltzmann fits to I~TAIL~ at negative voltages before and after exposure to ATP (open bar) or vehicle control (hatched bar). For E--G, data represent means ± SEM from *n* = 4 cells.](JGP_200910388_GS_Fig1){#fig1}

TRPV3 currents evoked by channel agonists such as 2-APB are potentiated by G~q/11~-coupled receptor stimulation in HEK-293 cells ([@bib86]), raising the question of whether native TRPV3 channels might be similarly modulated. We found that the amplitude of 2-APB--activated TRPV3 whole cell current in keratinocytes increased substantially (5.6 ± 1.6-- and 6.3 ± 1.9--fold at +80 and −80 mV, respectively) after exposure to the purinergic P2Y receptor agonist ATP ([Fig. 1, A, B, and E](#fig1){ref-type="fig"}). P2Y stimulation also altered the voltage dependence of native TRPV3 currents, such that half-maximal activation (V~0.5~) was shifted −61.7 ± 17.8 mV after exposure to ATP ([Fig. 1, C, D, and F](#fig1){ref-type="fig"}). In addition, the non-decaying portion of current increased substantially after ATP exposure ([Fig. 1 C](#fig1){ref-type="fig"}), and Boltzmann fits to the data clearly saturated at negative voltages, allowing us to calculate the change in the voltage-independent fraction (VIF) of TRPV3. Voltage-independent conducting modes have been previously reported for several TRP channels, including TRPV3 ([@bib14]). VIF increased 26.7 ± 5.1% after ATP exposure ([Fig. 1, D and G](#fig1){ref-type="fig"}), indicating that G~q~-coupled receptor activation not only modulates the voltage dependence of TRPV3 channels but also causes a significant fraction of the current to remain constitutively open. The activation of purinergic P2Y receptors therefore appears sufficient to increase the amplitude of TRPV3 currents in keratinocytes by causing a shift in voltage-dependent activation toward negative membrane potentials and increasing the size of TRPV3 current that flows at voltages where channels are normally closed.

To examine the mechanism of G~q/11~-coupled receptor potentiation of TRPV3 currents, we used the HM1 cell ([@bib62]) heterologous overexpression system that permits expression of recombinant TRPV3 channels together with recombinant human M~1~ ACh receptors. In HM1 cells, the M~1~ agonist CCh caused a larger potentiation of TRPV3 current amplitude (21.4- and 31.1-fold at +80 and −80 mV, respectively; [Fig. 2, A and C](#fig2){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}) than that seen in keratinocytes. The increased TRPV3 current amplitude and larger magnitude of G~q/11~-coupled receptor responses in HM1 cells facilitated our analysis of changes in TRPV3 channel properties. As in keratinocytes, G~q/11~-coupled receptor stimulation caused a large negative shift in V~0.5~ (−117.3 ± 19.4 mV; [Fig. 2, B and D](#fig2){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}) and an increase in VIF (23.1 ± 3.5%; [Fig. 2, B and E](#fig2){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}).

###### 

Effects of M1 receptor stimulation and PI 4 kinase inhibition on TRPV3 channel activity.

  Treatment:            CCh (+Ca^2+^~i~)   CCh (−Ca^2+^~i~)                         PAO                                                                                                                                               
  -------------- ------ ------------------ ---------------------------------------- ---------------------------------------- ------- ------- -------------------------------------- -------- ---------------------------------------- ----------------------------------------
  DNA:                  WT                 R696A                                    K705A                                    WT      R696A   K705A                                  WT       R696A                                    K705A
  Fold change    Mean   21.4               9.7                                      3.6[a](#tblfn1){ref-type="table-fn"}     2.9     4.0     1.5[a](#tblfn1){ref-type="table-fn"}   19.6     3.3[a](#tblfn1){ref-type="table-fn"}     1.5[a](#tblfn1){ref-type="table-fn"}
  SEM            1.6    3.3                0.3                                      0.4                                      0.6     0.1     5.6                                    1.0      0.1                                      
  ΔV~0.5~ (mV)   Mean   −117.3             −45.8[a](#tblfn1){ref-type="table-fn"}   −64.4[a](#tblfn1){ref-type="table-fn"}   −51.0   −35.1   −22.9                                  −109.9   −30.1[a](#tblfn1){ref-type="table-fn"}   −22.5[a](#tblfn1){ref-type="table-fn"}
  SEM            19.4   10.8               7.8                                      10.0                                     8.6     7.8     23.9                                   7.6      5.3                                      
  ΔVIF (%)       Mean   23.1               21.3                                     8.3[a](#tblfn1){ref-type="table-fn"}     5.5     24.0    1.3[a](#tblfn1){ref-type="table-fn"}   19.1     12.2                                     2.3[a](#tblfn1){ref-type="table-fn"}
  SEM            3.5    5.2                3.0                                      1.2                                      8.6     1.2     3.4                                    3.8      1.0                                      
                 *n*    8                  6                                        7                                        7       4       6                                      8        5                                        8

Effects of M~1~ stimulation (CCh) or PI 4 kinase inhibition (PAO) on current amplitude and voltage dependence for WT TRPV3, R696A, and K705A channels expressed in HM1 cells recorded with either 50 nM \[Ca^2+^~i~\] (+) or \<10 nM \[Ca^2+^~i~\] (−) to control PLCβ activity. Currents were recorded in the presence of 10 µM (WT), 3 µM (R696A), or 6 µM (K705A) 2-APB at +80 mV. Final drug concentrations: 100 µM CCh and 30 µM PAO.

P \< 0.05 comparing WT TRPV3 and R696A or K705A, respectively.

![Potentiation of recombinant expressed TRPV3 currents by G~q/11~-coupled muscarinic receptor activation. Whole cell currents were recorded from HM1 cells expressing WT TRPV3 under conditions that support (∼50 nM of free \[Ca^2+^\]~i~) or prevent (free \[Ca^2+^\]~i~, \<10 nM) PLCβ activity. (A) Representative current recordings elicited by voltage steps to +100 and −100 mV (upper panel, top) in the presence of 10 µM 2-APB before and after exposure to 100 µM CCh in the presence (lower panel) or absence (upper panel) of \[Ca^2+^\]. Dashed lines indicate the zero current level. (B) I~TAIL~--V relations for 2-APB--activated currents before (squares) and after (triangles) exposure to CCh in the presence (∼50 nM \[Ca^2+^\]~i~; filled symbols) or absence (\<10 nM \[Ca^2+^\]~i~; open symbols) of free Ca^2+^ in the pipette solution. Lines indicate fits to a Boltzmann function. (C) Average fold change in step current at +80 mV (white bars) and −80 mV (gray bars) after exposure to CCh in the presence (open bars) or absence (hatched bars) of \[Ca^2+^\]~i~. The average increase in TRPV3 current was 21.4 ± 4.5--fold at +80 mV (P = 0.0025) and 31.1 ± 7.9--fold at −80 mV (P = 0.0091). (D) Average change in V~0.5~ before and after CCh in the presence (open bar) or absence (hatched bar) of \[Ca^2+^\]~i~ (P = 0.014). (E) Average VIF determined from Boltzmann fits before and after exposure to CCh in the presence (open bars) or absence (hatched bars) of \[Ca^2+^\]~i~ (P \< 0.001, CCh + Ca^2+^ pre vs. post; P = 0.003, CCh + Ca^2+^ post vs. CCh − Ca^2+^ post). For C--E, data represent means ± SEM from *n* = 5--8 cells.](JGP_200910388_GS_Fig2){#fig2}

To test whether M~1~ modulation of TRPV3 required PLCβ activity, we omitted added Ca^2+^ from the BAPTA-buffered pipette solution, thereby reducing \[Ca^2+^\]~i~ from ∼50 to \<10 nM (refer to Materials and methods). Lowering \[Ca^2+^\]~i~ to a similar extent was previously shown to inhibit PLCβ activity and abrogate M~1~-dependent modulation of KCNQ2/3 channels expressed in HEK-293 cells ([@bib27]). Blocking PLCβ by decreasing \[Ca^2+^\]~i~ largely abolished the CCh-induced increase in TRPV3 current amplitude, negative shift in V~0.5~, and increase in VIF, but the effects of CCh were largely reversible on washout ([Fig. 2](#fig2){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}; not depicted). Activation of PLCβ by G~q/11~-coupled receptor is therefore sufficient to rapidly amplify TRPV3 currents in both native and heterologous cellular contexts.

Stimulation of G~q/11~-coupled receptors shifts TRPV3 agonist, voltage, and temperature sensitivity
---------------------------------------------------------------------------------------------------

In addition to modulating voltage-dependent activation of TRPV3, M~1~ stimulation altered the potency for TRPV3 channel activation by the chemical agonist 2-APB, as indicated by an approximately fourfold increase in 2-APB potency after CCh exposure ([Fig. 3 A](#fig3){ref-type="fig"}). To determine whether G~q/11~-coupled receptor modulation of TRPV3 activity requires channels to be simultaneously activated by the chemical agonist 2-APB, we measured voltage- and heat-activated currents before and after M~1~ stimulation in cells that were naive to 2-APB exposure ([Fig. 3](#fig3){ref-type="fig"}). Before CCh, TRPV3 tail currents were not readily detectable (up to +200 mV); after CCh, we observed voltage-dependent activation of TRPV3 at ∼+170 mV ([Fig. 3 B](#fig3){ref-type="fig"} and [Table II](#tbl2){ref-type="table"}). M~1~ activation caused the apparent threshold for thermal activation (T~h~) to shift −10°C ([Fig. 3, C, D, and F](#fig3){ref-type="fig"}), but the thermal coefficient (Q~10~) was changed only slightly by CCh exposure ([Fig. 3, D and E](#fig3){ref-type="fig"}), suggesting that G~q/11~-coupled receptor stimulation selectively affects the set point for thermal activation but not the fundamental mechanism of temperature sensing. Control recordings revealed only small and statistically insignificant changes in T~h~ and Q~10~ ([Fig. 3, D--F](#fig3){ref-type="fig"}). To rule out the possibility that heating induced a nonspecific leakage current, we superfused cells with NMDG at the peak of heat activation ([Fig. 3 C](#fig3){ref-type="fig"}). As expected, inward TRPV3 current was blocked, whereas outward currents were either unaffected or slightly potentiated ([@bib84]; [@bib14]). The sensitivity of TRPV3 channels to voltage, heating, and the chemical agonist 2-APB is therefore subject to modulation by receptor-catalyzed activation of PLCβ and increases the likelihood that channels will conduct current at typical skin temperature and resting membrane potential.

![Stimulation of G~q/11~-coupled receptors shifts TRPV3 agonist, voltage, and temperature sensitivity. (A) Concentration--response relation of 2-APB--activated currents recorded at +80 mV after exposure to either CCh (filled circles) or vehicle control (open circles). Solid lines represent fits to the Hill equation (CCh, EC~50~ = 6.7 ± 0.8 µM; vehicle control, EC~50~ = 28.6 ± 2.1 µM; *n* = 5 each). (B) Representative I~TAIL~--V relation of tail currents (measured at −100 mV) elicited by steps to the indicated voltages before (open circles) and after (filled circles) exposure to CCh. Apparent V~THR~ shifted from \>+200 mV before to +168.6 ± 9.6 mV (*n* = 7) after CCh exposure. (C) Representative currents at +80 mV (filled circles) or −80 mV (open circles) during repeated heating (17--40°C) in the absence or presence of CCh (open bar). The bath was superfused with NMDGCl (black bar) to check for inward leakage current after heating. (D) Representative temperature--current relations for heat-activated TRPV3 currents recorded in the presence of 100 µM CCh (filled circles) or vehicle control (open circles). Thermal coefficient (Q~10~) values were determined from linear fits to each of two distinct phases of temperature-dependent activation. (E) Average Q~10~ values for temperature-dependent activation at +80 mV before and after exposure to either CCh (open bars) or vehicle control (hatched bars). (F) Apparent thermal threshold (T~h~) for TRPV3 activation at +80 mV before and after exposure to CCh (filled circles; P \< 0.001) or vehicle control (open circles). Open squares represent means ± SEM. For E and F, data represent means ± SEM from *n* = 3--7 cells.](JGP_200910388_LW_Fig3){#fig3}

###### 

Effects of M~1~ receptor stimulation on WT and mutant TRPV3 channel properties

                             WT (before CCh)   WT (after CCh)                          R696A                                   K705A
  ------------------- ------ ----------------- --------------------------------------- --------------------------------------- ---------------------------------------
  2-APB EC~50~ (µM)   Mean   28.6              6.7[a](#tblfn2){ref-type="table-fn"}    11.9[a](#tblfn2){ref-type="table-fn"}   14.6[a](#tblfn2){ref-type="table-fn"}
                      SEM    2.1               0.8                                     1.0                                     2.1
                      *n*    5                 5                                       7                                       5
  V~THR~ (mV)         Mean   \>200             168.6                                   165.7                                   178.2
                      SEM                      9.6                                     11.3                                    5.7
                      *n*    7                 7                                       7                                       11
  T~h~ (°C)           Mean   28.4              18.3[a](#tblfn2){ref-type="table-fn"}   22.9[a](#tblfn2){ref-type="table-fn"}   23.5[a](#tblfn2){ref-type="table-fn"}
                      SEM    1.9               0.2                                     1.2                                     0.6
                      *n*    6                 6                                       7                                       6
  Arrhenius slope     Mean   7.2               10.3                                    5.6                                     8.3
                      SEM    0.9               1.1                                     0.5                                     0.4
                      *n*    6                 6                                       6                                       6

Effects of G~q/11~ activation and TRP domain mutations on 2-APB potency (EC~50~), apparent threshold for voltage-dependent activation (V~THR~), apparent threshold for temperature-dependent activation (T~h~), and Arrhenius slope of temperature-dependent activation for WT TRPV3, R696A, and K705A channels expressed in HM1 cells at +80 mV (except for V~THR~).

P \< 0.05 compared to WT TRPV3 before CCh by Student's non-paired *t* test.

PI(4,5)P~2~ depletion potentiates 2-APB--activated TRPV3 currents
-----------------------------------------------------------------

Given that TRPV3 activity is positively modulated by G~q/11~-coupled receptors and related TRP channels are regulated by PI(4,5)P~2~, we wondered whether a PLCβ-catalyzed decrease in membrane PI(4,5)P~2~ levels could account for the changes in TRPV3 properties that we observed. We therefore measured 2-APB--activated current before and after treating cells with drugs that block either PI 3 kinase (10 nM WM) or PI 4 kinase (30 µM PAO or 10 µM WM) ([@bib55]; [@bib81]; [@bib78]; [@bib74], [@bib75]). PAO treatment resulted in a strong potentiation of TRPV3 current (19.6 ± 5.6--fold) that was similar to the effect of M~1~ stimulation ([Fig. 4, A and C](#fig4){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}). Like CCh, PAO caused V~0.5~ to shift −109.9 ± 23.9 mV and VIF to increase 19.1 ± 3.4% ([Fig. 4, B, D, and E](#fig4){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}). At 10 µM, the effect of WM on V~0.5~ and VIF (ΔV~0.5~ = −98.4 ± 18.6 mV; ΔVIF = 19.7 ± 3.8%; *n* = 5) was similar to PAO, but the average current potentiation by 10 µM WM (9.6 ± 2.2-- and 13.2 ± 2.8--fold increase at +80 and −80 mV, respectively) was less robust and failed to reach statistical significance (+80 mV, P = 0.06; −80 mV, P = 0.27; by Student's nonpaired *t* test). Although the data suggest that 30 µM PAO and 10 µM WM similarly affect TRPV3 activity by inhibiting PI 4 kinase, the effects of the two drugs at the concentrations tested are not identical. At a lower concentration (10 nM), the effect of WM was similar to vehicle control ([Fig. 4, A--E](#fig4){ref-type="fig"}), suggesting that PI 3 kinase activity is unlikely to participate in G~q/11~-coupled receptor modulation of TRPV3 under our experimental conditions.

![PI(4,5)P~2~ depletion potentiates 2-APB--activated TRPV3 currents. HM1 cells expressing WT TRPV3 were treated for 2 min (CCh) or 5 min (PAO and WM) with the indicated drug, and currents were elicited in the presence of 10 µM 2-APB. (A) Representative currents resulting from voltage steps to +100 and −100 mV after treatment with the indicated drugs. (B) Representative I~TAIL~--V relations from the same cells as current traces shown in A. (C) Average fold change in step current at +80 mV (open bars) and −80 mV (gray bars) elicited by treatment with the indicated drugs or vehicle control. (D and E) Average changes in V~0.5~ (D) and VIF (E) under the indicated conditions. In D and E, bar shading represents CCh alone (open), PAO (diagonally hatched), CCh plus PAO (gray), WM (crosshatched), or vehicle control (black). Final drug concentrations in A--E: CCh, 100 µM; PAO, 30 µM; WM, 10 nM. For C--E, data represent means ± SEM from *n* = 5--8 cells. See [Table I](#tbl1){ref-type="table"} for a summary of the data.](JGP_200910388_GS_Fig4){#fig4}

Combining PI 4 kinase inhibition (PAO) and CCh simulation resulted in greater current potentiation, a further negative shift in V~0.5~, and a larger increase in VIF than was seen with either agent alone ([Fig. 4](#fig4){ref-type="fig"}). One possible explanation is that inhibiting PI(4,5)P~2~ synthesis while simultaneously stimulating its hydrolysis more profoundly or persistently decreases the amount of plasma membrane PI(4,5)P~2~, resulting in a larger effect on TRPV3 channels. Alternatively, the combined effect of CCh and PAO may indicate that other signaling molecules downstream of M~1~ activation, such as DAG, modulate TRPV3 activity. Collectively, our data suggest that depleting PI(4,5)P~2~ is at least partially sufficient to modulate both voltage-dependent and voltage-independent activation of TRPV3 channels.

TRPV3 channel activity in excised patches is stimulated by PI(4,5)P~2~ depletion
--------------------------------------------------------------------------------

To more directly determine whether PI(4,5)P~2~ is necessary for controlling basal TRPV3 channel activity, we treated excised inside-out patches with agents that are known to decrease membrane PI(4,5)P~2~ levels ([@bib75]). Spontaneous TRPV3 channel open probability (NP~OPEN~) after patch excision was typically low (refer to Materials and methods), but the addition of the PI(4,5)P~2~-scavenging mAb ([@bib88]; [@bib1]; [@bib75]) caused NP~OPEN~ to increase (NP~OPEN~ = 0.005 ± 0.002 before mAb; NP~OPEN~ = 0.64 ± 0.23 after mAb; [Fig. 5, A--C](#fig5){ref-type="fig"}). In contrast, control recordings showed only a negligible increase in NP~OPEN~ over the same 8-min incubation period (initial NP~OPEN~ = 0.015 ± 0.007; final NP~OPEN~ = 0.085 ± 0.055; [Fig. 5, B and C](#fig5){ref-type="fig"}). Purified bacterial PI-PLC ([@bib76]; [@bib75]) essentially mimicked the effect of mAb, causing TRPV3 channel activity to persistently increase (NP~OPEN~ = 0.021 ± 0.006 before PI-PLC; NP~OPEN~ = 0.89 ± 0.24 after PI-PLC; [Fig. 5, B and C](#fig5){ref-type="fig"}). In contrast to its effect on TRPC6 channels ([@bib26]), the DAG analogue 1-oleoyl-2-acetyl-*sn*-glycerol (OAG; 100 µM) did not significantly increase TRPV3 channel activity (NP~OPEN~ = 0.025 ± 0.021 before OAG; NP~OPEN~ = 0.069 ± 0.031 after OAG; [Fig. 5, B and C](#fig5){ref-type="fig"}), suggesting that DAG production alone is not sufficient to potentiate TRPV3. Our results therefore suggest that depleting PI(4,5)P~2~ increases the open probability of TRPV3 channels by sensitizing the channel to activation by other stimuli (i.e., thermal heating, membrane depolarization, and chemical agonists). PI(4,5)P~2~ thus appears necessary to maintain tonic inhibition of TRPV3 channel activity under typical resting cellular conditions.

![TRPV3 channel activity in excised patches is stimulated by PI(4,5)P~2~ depletion. Inside-out patches pulled from HM1 cells expressing WT TRPV3 were exposed to either anti-PI(4,5)P~2~ mAb or PI-PLC for 5 min, or OAG for 2 min (V~m~ = +80 mV). (A) A representative current record (left) showing the potentiating effect of mAb (1:200 dilution) on TRPV3 channel activity. Open boxes before (*a*) and after (*b*) reagent addition indicate time segments used for determination of NP~OPEN~. Expanded current traces (right) during the time period shown in box *a* or *b*. The level of current associated with the indicated number of open TRPV3 channels is shown on the left. (B) Selected all-points histograms showing TRPV3 channel activity in patches before and after treatment with vehicle control, mAb (1:200 dilution; data from A), 100 µM OAG, or 0.5 U/ml PI-PLC. (C) Mean calculated NP~OPEN~ values before and after reagent addition in patches treated with vehicle control (*n* = 7), mAb (*n* = 7), OAG (*n* = 11), or PI-PLC (*n* = 29). Error bars represent SEM; \*, P \< 0.05; \*\*, P \< 0.001 versus control after vehicle addition by Student's nonpaired *t* test.](JGP_200910388_GS_Fig5){#fig5}

To determine whether PI(4,5)P~2~ was sufficient to decrease TRPV3 channel NP~OPEN~, we applied a synthetic water-soluble analogue, diC8-PI(4,5)P~2~ (dioctanoyl PI(4,5)P~2~ or [d]{.smallcaps}-myo-phosphatidylinositol 4,5-bisphosphate C8) to the intracellular side of excised inside-out patches that had been previously treated with mAb or PI-PLC. Between 3 and 60 µM, diC8-PI(4,5)P~2~ decreased PI-PLC--stimulated TRPV3 channel activity in a concentration-dependent fashion that was well fit to the Hill equation (IC~50~ = 10.0 ± 4.5 µM; *n* = 5 different patches; [Fig. 6, A and D](#fig6){ref-type="fig"}). Similar results were seen when TRPV3 channels were activated by PI(4,5)P~2~ depletion with mAb ([Fig. 6 C](#fig6){ref-type="fig"}). TRPV3 activity rapidly returned after diC8-PI(4,5)P~2~ washout in four of six patches, and the addition of either vehicle control or other diC8-phosphatidylinositol polyphosphates (PI(3,4,5)P~3~ or PI(3,5)P~2~) or monophosphates (PI(3)P, PI(4)P, or PI(5)P) at 30 µM failed to significantly decrease NP~OPEN~ ([Fig. 6, B and E](#fig6){ref-type="fig"}).

![PI(4,5)P~2~ decreases TRPV3 single-channel open probability. Inside-out patches excised from HM1 cells expressing WT TRPV3 (V~m~ = +80 mV) were treated with 0.5 U/ml PI-PLC (open bar), followed by water-soluble diC8-phosphatidylinositol phosphate analogues. (A and B) Representative current records showing the \[diC8-PI(4,5)P~2~\]--dependent decrease in TRPV3 channel activity (A) and lack of similar effect in vehicle-treated patches (B). Filled bars in B represent serial dilutions of vehicle that mimic those used to achieve the indicated \[diC8-PI(4,5)P~2~\] shown in A. (C) A representative patch recording in which TRPV3 activity was stimulated by mAb and reversibly inhibited by 30 µM diC8-PI(4,5)P~2~. (D) The average diC8-PI(4,5)P~2~ concentration--response relation (data represent means ± SEM; *n* = 5 patches). Solid line represents a Hill fit to the data for 1--60 µM diC8-PI(4,5)P~2~ (IC~50~ = 10.0 ± 4.5 µM). (E) Average change in NP~OPEN~ induced by the addition of the indicated diC8-phosphatidylinositol phosphates. Data represent means ± SEM from *n* = 3--6 patches.](JGP_200910388_LW_Fig6){#fig6}

Although low concentrations (0.1--1 µM) of diC8-PI(4,5)P~2~ sometimes appeared to stimulate TRPV3 activity relative to NP~OPEN~ measured after washout of PI(4,5)P~2~-depleting agents ([Fig. 6, A and D](#fig6){ref-type="fig"}), this effect was inconsistent, and similar time-dependent changes in NP~OPEN~ after PI-PLC washout were also seen in some vehicle-treated patches ([Fig. 6 B](#fig6){ref-type="fig"}). A simple explanation for the data from excised patches is that TRPV3 activity is selectively inhibited by PI(4,5)P~2~ in cell-free membrane patches.

Effects of mutating putative PI(4,5)P~2~-binding residues in the TRP domain of TRPV3
------------------------------------------------------------------------------------

To identify specific residues that are required for PLCβ- and PI(4,5)P~2~-dependent modulation of TRPV3, we mutated two conserved basic residues in the TRP domain (R696A and K705A; [Fig. 7 A](#fig7){ref-type="fig"}) that had been previously identified as potential PI(4,5)P~2~-interacting residues in TRPV1 and TRPV5 ([@bib67]; [@bib6]). Both R696A and K705A expressed robust 2-APB--activated and voltage-dependent whole cell currents, but M~1~-dependent channel modulation of the mutant channels was attenuated compared with WT TRPV3 ([Fig. 7](#fig7){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). Stimulation of M~1~ by CCh caused 2-APB--activated current to increase only 9.7-fold and 3.6-fold in cells expressing R696A or K705A, respectively ([Fig. 7, B, D, G, and I](#fig7){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}), which was significantly less than the 21.4-fold potentiation seen for WT TRPV3 ([Fig. 2](#fig2){ref-type="fig"}). The CCh-induced negative shift in V~0.5~ observed for WT TRPV3 was also significantly attenuated in both R696A and K705A ([Fig. 7, C, E, H, and J](#fig7){ref-type="fig"}, and [Table I](#tbl1){ref-type="table"}). Despite their similarity, some functional differences between R696A and K705A were noted. Whereas M~1~ stimulation increased VIF of K705A channels only 8.3% in the presence of 50 nM \[Ca^2+^\]~i~ (compared with 23.1% for WT TRPV3), VIF increased 21.3% for R696A ([Fig. 7](#fig7){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). Unlike WT TRPV3 and K705A, the increase in VIF for R696A appeared to be independent of \[Ca^2+^\]~i~ ([Table I](#tbl1){ref-type="table"}). The effects of neutralizing mutations at Arg696 and Lys705 support the hypothesis that TRP domain residues are required for the robust potentiation of TRPV3 channel activity resulting from receptor-mediated PI(4,5)P~2~ hydrolysis or pharmacological depletion of PI(4,5)P~2~.

![Effects of G~q/11~-coupled receptor activation are attenuated in TRP domain mutants. (A) Sequence alignment of TRP domains from TRPV1, TRPV3, and TRPV5. Numbers indicate starting position in the amino acid sequence of human TRPV1 (NCBI Protein database accession no. [NM_080705](NM_080705)), human TRPV3 ([AF514998.1](AF514998.1)), and human TRPV5 ([NM_019841](NM_019841)). Residues that are identical to TRPV3 are shown in gray, and basic residues previously identified as being important for PI(4,5)P~2~-dependent modulation of TRPV1 and TRPV5 that are conserved in TRPV3 are shown within open boxes. Asterisks denote positions of TRPV3 mutations reported here. Whole cell currents were recorded from HM1 cells transfected with TRPV3 R696A (B--F) or K705A (G--K). M~1~ was activated by bath application of 100 µM CCh in the presence (CCh + Ca^2+^) or absence (CCh − Ca^2+^) of buffered free \[Ca^2+^\]~i~, as described in [Fig. 2](#fig2){ref-type="fig"}. Cells were incubated with 30 µM PAO for 5 min between the first and second 2-APB applications to inhibit PI 4 kinase activity. The 2-APB concentrations used for R696A and K705A were 3 and 6 µM, respectively. (B and G) Representative current records (bottom) elicited by steps to the indicated voltages (top) recorded under the following conditions: CCh + Ca^2+^ (black circles), CCh − Ca^2+^ (gray squares), and PAO (gray triangles). The zero current level is indicated by a solid line. (C and H) Representative I~TAIL~--V relations from the cells shown in B and G under the following conditions: CCh + Ca^2+^ (circles), CCh − Ca^2+^ (squares), and PAO (triangles). Lines represent fits to a Boltzmann function. (D and I) Average fold change in current amplitude at +80 mV (open bars) and −80 mV (black bars) elicited by treatment under the indicated conditions. (E and J) Average change in V~0.5~ (ΔV~0.5~ = ΔV~0.5\ POST~ − ΔV~0.5\ PRE~) measured in cells treated under the indicated conditions. (F and K) Average change in VIF (VIF~POST~ − VIF~PRE~) before and after treatment under the following conditions: CCh + Ca^2+^ (open bars), CCh − Ca^2+^ (diagonally hatched bars), and PAO (crosshatched bars). For D--F and I--K, data represent means ± SEM from *n* = 5--7 cells.](JGP_200910388_GS_Fig7){#fig7}

R696 and K705 contribute to ligand, voltage, and temperature sensitivity in TRPV3
---------------------------------------------------------------------------------

Because M~1~ stimulation altered the sensitivity of WT TRPV3 to activation by 2-APB, voltage, and temperature ([Fig. 3](#fig3){ref-type="fig"}), and the R696A and K705A mutations were both much less sensitive to G~q/11~-dependent modulation ([Fig. 7](#fig7){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}), we reasoned that both mutations might also affect 2-APB potency, voltage-dependent activation, and apparent thermal threshold. As summarized in [Table II](#tbl2){ref-type="table"}, 2-APB activated R696A and K705A currents approximately twofold more potently than it did WT TRPV3. V~THR~ measured in the absence of CCh was also more negative for both R696A and K705A than it was for WT TRPV3 ([Table II](#tbl2){ref-type="table"} and [Fig. S2](http://www.jgp.org/cgi/content/full/jgp.200910388/DC1)). In addition, T~h~ for R696A and K705A was shifted toward cooler temperatures compared with WT TRPV3 ([Table II](#tbl2){ref-type="table"} and Fig. S2). Interestingly, V~THR~, 2-APB EC~50~, and T~h~ values for R696A and K705A under resting conditions (i.e., without M~1~ activation) were similar to those found for WT TRPV3 after G~q/11~-dependent receptor stimulation ([Table II](#tbl2){ref-type="table"}), suggesting that these basic residues in the TRP domain contribute to the modulation of voltage, temperature, and chemical ligand sensitivity in TRPV3.

TRP domain--mutant channel activity is unaffected by PI(4,5)P~2~ depletion
--------------------------------------------------------------------------

To determine whether the R696A and K705A mutations affected the sensitivity of TRPV3 to PI(4,5)P~2~, we measured TRPV3 single-channel currents in excised patches treated with PI(4,5)P~2~-depleting agents and diC8-PI(4,5)P~2~. Spontaneous (basal) channel activity during the first 2 min after patch excision was sevenfold and 23-fold higher for R696A (NP~OPEN~ = 0.13 ± 0.06; [Fig. 8, A--C](#fig8){ref-type="fig"}) and K705A (NP~OPEN~ = 0.45 ± 0.10; [Fig. 8, D--F](#fig8){ref-type="fig"}), respectively, than for WT TRPV3 (basal NP~OPEN~ = 0.02 ± 0.004; [Fig. 5](#fig5){ref-type="fig"}). The single-channel conductances of R696A (175.5 ± 2.6 pS) and K705A (178.0 ± 3.2 pS) were similar to WT TRPV3 (180.8 ± 2.4 pS). The addition of either mAb or PI-PLC failed to cause a significant increase in NP~OPEN~ for either mutant compared with vehicle controls ([Figs. 8](#fig8){ref-type="fig"} and [S3](http://www.jgp.org/cgi/content/full/jgp.200910388/DC1)). Likewise, R696A and K705A channel activity was unaffected by the addition of 30 µM diC8-PI(4,5)P~2~ ([Figs. 8, B and E](#fig8){ref-type="fig"}, and S3), which exhibited a nearly maximal inhibitory effect on WT TRPV3 NP~OPEN~ ([Fig. 6](#fig6){ref-type="fig"}). Collectively, our findings indicate that TRPV3 channel activity is negatively regulated by resting PI(4,5)P~2~ levels in the plasma membrane, and that basic residues in the TRP domain are essential for the effects of PI(4,5)P~2~ on TRPV3.

![The TRP domain mutants R696A and K705A are insensitive to changes in PI(4,5)P~2~. Inside-out patches were excised from HM1 cells expressing TRPV3 R696A or K705A, and voltage was clamped at +80 mV. (A and D) Representative current records from inside-out patches exposed to mAb (1:200 dilution; black bars, left). Open boxes indicate the time segments used for analysis of single-channel properties (*a*, before exposure to mAb; *b*, after exposure to mAb). Expanded current traces (right) during the time period shown in box *a* or *b*. (B and E) All-points histograms of raw data shown in A and D and similar recordings (see Fig. S3) in nontreated controls or patches treated with 0.5 U/ml PI-PLC and 30 µM diC8-PI(4,5)P~2~. (C and F) Average NP~OPEN~ in patches expressing R696A or K705A either before (open bars) or after (black bars) the addition of mAb or PI-PLC, or in nontreated control recordings. Data represent means ± SEM from *n* = 3--5 patches.](JGP_200910388_GS_Fig8){#fig8}

DISCUSSION
==========

Keratinocytes reside in close proximity to sensory nerve endings and leukocytes in skin, and bidirectional communication between different cell types is mediated by a variety of paracrine signaling molecules including G protein--coupled receptor agonists ATP, serotonin, histamine, prostaglandin E2, and leukotriene B4, and cytokines such as IL-1α, IL-6, IL-8, IL-17, IFN-γ, and TNF ([@bib50]; [@bib17]; [@bib21]; [@bib39]; [@bib46]; [@bib32]; [@bib90]). Temperature-sensitive TRPV3 channels are highly expressed in keratinocytes, and thermal or mechanical stimulation of keratinocytes causes ATP release, which might cause autocrine stimulation of purinergic P2Y receptors ([@bib61]; [@bib70]; [@bib84]; [@bib39]; [@bib34]). ATP, histamine, and serotonin are known to generate a transient rise in \[Ca^2+^\]~i~ via receptor-mediated PLCβ activation and to stimulate keratinocyte proliferation, which is required for wound healing ([@bib50]; [@bib41]; [@bib21]; [@bib7]; [@bib23]). TRPV3 current is potentiated by G~q/11~-coupled receptors in a heterologous overexpression system ([@bib86]), suggesting that native TRPV3 channels could be subject to a similar regulatory mechanism in keratinocytes.

We show here that primary human keratinocytes express voltage- and agonist-evoked currents with biophysical and pharmacological properties that are strikingly similar to expressed TRPV3 channels. Extracellular ATP potentiated agonist-evoked TRPV3 current amplitude, shifted voltage-dependent activation toward negative potentials, and increased the proportion of voltage-independent current in both primary keratinocytes and HM1 cells, indicating that native and expressed TRPV3 channels are stimulated by similar mechanisms. The increased susceptibility to dermatitis and inflammatory skin lesions in hairless rodents bearing constitutively active TRPV3 channel mutations demonstrates that elevated TRPV3 activity is sufficient to dramatically alter skin health ([@bib3]; [@bib83]; [@bib33]; [@bib87]). TRPV3 channels regulate growth factor receptor signaling and are required for TGF-α release ([@bib9]) and may also control the release of paracrine messengers (i.e., ATP, prostaglandin E2) from keratinocytes ([@bib32]; [@bib48]).

Consistent with previous reports describing activation mechanisms in TRPV1 and TRPM8 ([@bib64]; [@bib67]; [@bib6]; [@bib80]), we also found that the voltage, temperature, and agonist sensitivity of TRPV3 are coordinately modulated by G~q/11~-coupled receptor stimulation. Both receptor-mediated PLCβ activation and pharmacological depletion of PI(4,5)P~2~ were sufficient to cause a large negative shift in the voltage dependence of TRPV3 activation and increase the proportion of voltage-independent current. M~1~ stimulation also increased the potency for 2-APB to activate TRPV3 current and shifted thermal activation toward cooler temperatures without significantly affecting Q~10~. The inhibition of PI 4 kinase (but not PI 3 kinase) largely mimicked the M~1~ effect, suggesting that CCh modulation of TRPV3 is primarily attributable to receptor-catalyzed hydrolysis of PI(4,5)P~2~. Buffering \[Ca^2+^\]~i~ below 10 nM was previously demonstrated to prevent PLCβ-dependent modulation of KCNQ2/3 channels ([@bib27]), and this maneuver also significantly attenuated the CCh-dependent effects on TRPV3 measured here.

DAG that is generated by PLCβ (and the PI-PLC used in excised patch recordings) may contribute to the increases in TRPV3 channel activity observed in some of our experiments. PI(4,5)P~2~ and DAG were shown to coordinately regulate mammalian TRPC6 ([@bib26]; [@bib24]; [@bib1]) and *Drosophila melanogaster* TRPL ([@bib18]) channel activities. However, a DAG analogue (OAG) failed to significantly elevate NP~OPEN~ in excised patches containing TRPV3 channels. In vitro depletion of PI(4,5)P~2~ therefore appears to be sufficient to increase TRPV3 channel activity, but our data do not rule out the possibility that DAG (or other signaling molecules) generated by G~q~-coupled receptor stimulation could also stimulate TRPV3 under different experimental conditions. Indeed, the synergistic effect of M~1~ activation in cells pretreated with the PI 4 kinase inhibitor PAO is consistent with the possibility that another factor, possibly DAG, could increase TRPV3 current after PI(4,5)P~2~ becomes depleted. Additional studies to elucidate other potentially important mechanisms of TRPV3 regulation are required. However, lowering \[PI(4,5)P~2~\] by the addition of mAb to inside-out patches was sufficient to increase TRPV3 channel activity, indicating that PLCβ activity is not a prerequisite for TRPV3 sensitization. We therefore conclude that TRPV3 channel activity is subject to negative regulation by resting levels of PI(4,5)P~2~ in plasma membrane, such that the activation of G~q/11~-coupled receptors leads to a rapid and dramatic increase in channel activity.

The large unitary conductance and high Ca^2+^ permeability of TRPV3 channels suggest that under physiological conditions, even a moderate elevation in TRPV3 channel opening is likely to have profound consequences for voltage- and Ca^2+^-dependent cellular processes. Indeed, expression of constitutively active mutant TRPV3 channels or strong activation of related TRPV1 channels by capsaicin causes cell death both in vitro and in vivo ([@bib73]; [@bib36]; [@bib83]). Regulation of TRPV3 channel activity by PLC-coupled receptor-catalyzed PI(4,5)P~2~ hydrolysis represents a plausible mechanism for maintaining strict control of basal channel activity under resting conditions while also allowing for rapid and reversible amplification of TRPV3 responses. TRPV3-mediated Ca^2+^ influx and depolarization thus allows for temporal and spatial control of signaling cascades that may control release of factors that are known to modulate inflammation, hair growth, keratinocyte differentiation, wound healing, and thermosensation ([@bib7]; [@bib46]; [@bib23]; [@bib9]).

Changes in membrane PI(4,5)P~2~ levels are known to modulate the activity of several TRP channels ([@bib18]; [@bib69]; [@bib42]; [@bib43]; [@bib67]; [@bib57], [@bib59]; [@bib37]; [@bib60]; [@bib66]; [@bib51]; [@bib77]). In a subset of TRP channels, basic residues in the TRP domain were proposed to mediate PI(4,5)P~2~ binding ([@bib59]; [@bib66]). We found that TRPV3 channels are also sensitive to PI(4,5)P~2~ in both whole cell and excised patch recording configurations and show here that neutralizing mutations of TRP domain residues R696 and K705 largely abrogate the effects of techniques designed to reduce PI(4,5)P~2~ levels in both whole cell and excised patch configurations. In addition, V~THR~, T~h~, and 2-APB potency values in R696A and K705A mimicked those seen for WT TRPV3 after M~1~ activation, indicating that both residues are required for normal modulation of TRPV3 downstream of PLCβ. Elevated WT TRPV3 channel activity resulting from PI(4,5)P~2~ depletion was reversed by the addition of water-soluble diC8-PI(4,5)P~2~ with an IC~50~ of ∼10 µM. PI(4,5)P~2~ therefore appears to modulate TRPV3 with potency comparable to other "high affinity" channels such as Kir2.1 ([@bib31]; [@bib38]). Despite exhibiting higher basal activities than WT TRPV3, both R696A and K705A mutants were insensitive to diC8-PI(4,5)P~2~, suggesting that PI(4,5)P~2~ could exert its effects on TRPV3 gating by directly interacting with these residues.

Electrostatic interactions between positively charged side chains of Arg and Lys residues and negatively charged phosphates on the inositol ring appear to be essential components of discrete PI(4,5)P~2~-binding sites in a variety of ion channels and transporters ([@bib68]; [@bib75]). R696 and K705 in TRPV3 are homologous to conserved basic residues that are thought to participate in PI(4,5)P~2~ interactions in several other TRP channels ([@bib67]; [@bib6]). However, most of the tools commonly used to study ion channel interactions with PIPs do not directly measure lipid binding to functional channels under voltage control, and even excised membrane patches could include cytosolic enzymes that regulate lipid turnover and modulate channel activity. Although the effect of PI(4,5)P~2~ on TRPV3 activity may therefore be indirect and require interactions with channel-associated PI(4,5)P~2~-binding proteins ([@bib75]), a recent report showed that the TRPV1-interacting and PI(4,5)P~2~-binding protein Pirt is not required for channel activation by PI(4,5)P~2~ ([@bib77]). Our data are consistent with the large body of experimental evidence indicating that PIP binding to basic residues directly regulates the activity of many ion channels and transporters ([@bib68]; [@bib75]; [@bib77]).

The rapid shift in TRPV3 voltage dependence that we observed after M~1~ stimulation in HM1 cells or P2Y stimulation in keratinocytes is reminiscent of the effect of prolonged heating or exposure to high concentrations of channel agonists such as 2-APB ([@bib14]). Previous studies concluded that both TRPV1 and TRPV3 channels undergo an apparently irreversible transition from voltage-dependent ("I1") to voltage-independent ("I2") conducting modes. Entry into I2 mode was shown to be accompanied by changes in T~h~, 2-APB potency, and ion selectivity ([@bib14], [@bib15]; [@bib8]). Although transition to I2 is reported to be irreversible, we show that the activation of G~q/11~-coupled receptors reversibly promotes occupancy of a voltage-independent TRPV3 gating mode that shares at least some properties with I2. Although detailed mechanistic explanations for agonist-, time-, and PI(4,5)P~2~-dependent changes in TRPV3 gating require further investigation, studies on related TRP channels may provide some insight.

The voltage dependence of TRPM8, TRPA1, and TRPM4 is also subject to modulation by channel ligands, and under some circumstances, these channels also generate voltage-independent current ([@bib89]; [@bib57]; [@bib49]; [@bib8]). Although the voltage-independent opening of TRP channels argues against an obligatory voltage-dependent transition in activation gating ([@bib6]; [@bib49]; [@bib58]), it remains possible that voltage-independent current actually reflects a shift in voltage sensitivity to extremely negative potentials that are outside of the readily measurable range, using standard voltage clamp techniques (typically −200 to +200 mV). Nonetheless, G~q/11~-coupled receptor modulation of TRPV3 leads to an increase in the probability that channels will generate current at the resting membrane potential, effectively abrogating the effect of hyperpolarizing voltage to induce channel closure.

The discovery of heat-insensitive but agonist- and voltage-sensitive TRPV3 pore domain mutants also demonstrates that voltage-dependent gating is separable from other modes of activation, at least in TRPV3 channels ([@bib22]). Residues in S4 and the S4--S5 linker of TRPM8 were reported to contribute to voltage sensitivity in TRPM8 ([@bib80]), and point mutations of G573 in mouse TRPV3 that cause constitutive voltage-independent opening are also predicted to lie in the S4--S5 linker ([@bib83]). The high resolution structure of a mammalian voltage-dependent K^+^ channel suggests that voltage-dependent movement of S4 gating is coupled to pore opening via interactions between residues in the S4--S5 linker and C-terminal end of S6 ([@bib44]). The TRP domain is located at the intracellular end of S6, potentially placing it in proximity to the S4--S5 linker if basic channel architecture is similar in TRP channels and voltage-gated K^+^ channels. Docking stimulations of a full atom--refined model of TRPV1 place the PI(4,5)P~2~ polar head in position to interact with positive charges located in the TRP domain and the S4--S5 linker. Residues homologous to R696 and K705 lie on opposite sides of a putative PI(4,5)P~2~-binding pocket and may differentially affect voltage sensing ([@bib6]). Additional residues in the proximal C terminus could also be required for PI(4,5)P~2~ binding in TRP channels ([@bib77]). The molecular determinants of voltage sensitivity and PI(4,5)P~2~ binding may therefore lie in close proximity, perhaps explaining the typically close coupling between voltage and lipid sensitivity ([@bib58]), and perhaps offering some insight into the differences in voltage-dependent gating between R696A and K705A observed here.

Unlike prototypical voltage-gated K^+^ channels, in which voltage sensing is obligately coupled to channel opening, TRP channels appear to share more functional homology with Ca^2+^-activated K^+^ (BK) channels wherein voltage dependence is modulated by a ligand, \[Ca^2+^\]~i~ ([@bib47]; [@bib28]; [@bib5]). A cogent and detailed understanding of gating mechanisms in polymodal TRPs and other channels activated by multiple stimuli will likely require a combination of high resolution protein structure, computer simulation, direct measurement of ligand--channel and lipid--channel interactions, and real-time electrophysiological analysis of channel function. Determining whether bound PI(4,5)P~2~ directly participates in the formation or function of sensors for voltage, heat, and chemical ligands, or merely influences the function of other motifs that separately comprise sensors for various activation stimuli in TRPV3 and related channels, is a goal for future study.

In summary, we showed that native TRPV3 channels in primary human keratinocytes and recombinant TRPV3 channels expressed in HEK-293 cells are strongly modulated by stimulation of G~q/11~-coupled receptors. PLCβ-catalyzed hydrolysis of PI(4,5)P~2~ accounts for most of the observed effects on TRPV3 channel activity: (a) a potentiation of current amplitude that is driven by a negative shift in the voltage dependence of opening and an increase in the fraction of channels that conduct in a voltage-independent mode; and (b) a decrease in the apparent threshold for thermal activation. Each of these effects will tend to increase the likelihood that TRPV3 channels will be open under physiological conditions. Two basic residues in the TRP domain are required for G~q/11~-coupled receptor modulation of TRPV3 and could participate in PI(4,5)P~2~ binding. We hypothesize that PI(4,5)P~2~-bound TRPV3 channels open only rarely and that PLC activity or PI(4,5)P~2~ depletion provides relief of tonic inhibition. PI(4,5)P~2~ thus appears well suited to regulate TRPV3 channel activity in vivo and thereby control Ca^2+^-dependent cellular signaling in keratinocytes or other cells expressing TRPV3.
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